Ciliary Neurotrophic Factor Protects Mice Against Streptozotocin-induced Type 1 Diabetes Through Socs3: The Role Of Stat1/stat3 Ratio In β-cell Death

Type 1 diabetes is characterized by a loss of islet β-cells. Ciliary neurotrophic factor (CNTF) protects pancreatic islets against cytokine-induced apoptosis. For this reason, we assessed whether CNTF protects mice against streptozotocin-induced diabetes (a model of type 1 diabetes) and the mechanism for this protection. WT and SOCS3 knockdown C57BL6 mice were treated for 5 days with citrate buffer or 0.1 mg/kg CNTF before receiving 80 mg/kg streptozotocin. Glycemia in nonfasted mice was measured weekly from days 0-28 after streptozotocin administration. Diabetes was defined as a blood glucose > 11.2 mmol/liter. Wild-type (WT) and SOCS3 knockdown MIN6 cells were cultured with CNTF, IL1β, or both. CNTF reduced diabetes incidence and islet apoptosis in WT but not in SOCS3kd mice. Likewise, CNTF inhibited apoptosis in WT but not in SOCS3kd MIN6 cells. CNTF increased STAT3 phosphorylation in WT and SOCS3kd mice and MIN6 cells but reduced STAT1 phosphorylation only in WT mice, in contrast to streptozotocin and IL1β. Moreover, CNTF reduced NFκB activation and required down-regulation of inducible NO synthase expression to exert its protective effects. In conclusion, CNTF protects mice against streptozotocin-induced diabetes by increasing pancreatic islet survival, and this protection depends on SOCS3. In addition, SOCS3 expression and β-cell fate are dependent on STAT1/STAT3 ratio. © 2012 by The American Society for Biochemistry and Molecular Biology, Inc.287504162841639Gysemans, C.A., Ladriere, L., Callewaert, H., Rasschaert, J., Flamez, D., Levy, D.E., Matthys, P., Mathieu, C., Disruption of the γ-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of β-cells (2005) Diabetes, 54 (8), pp. 2396-2403. , DOI 10.2337/diabetes.54.8.2396Cardozo, A.K., Heimberg, H., Heremans, Y., Leeman, R., Kutlu, B., Kruhøffer, M., Ørntoft, T., Eizirik, D.L., A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells (2001) J. Biol. Chem., 276, pp. 48879-48886Eizirik, D.L., Mandrup-Poulsen, T., A choice of death - The signal-transduction of immune-mediated beta-cell apoptosis (2001) Diabetologia, 44 (12), pp. 2115-2133. , DOI 10.1007/s001250100021Cnop, M., Welsh, N., Jonas, J.C., Jörns, A., Lenzen, S., Eizirik, D.L., Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: Many differences, few similarities (2005) Diabetes, 54, pp. S97-S107Kishimoto, T., Akira, S., Narazaki, M., Taga, T., Interleukin-6 family of cytokines and gp130 (1995) Blood, 86, pp. 1243-1254Stockli, K.A., Lillien, L.E., Naher-Noe, M., Breitfeld, G., Hughes, R.A., Raff, M.C., Thoenen, H., Sendtner, M., Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain (1991) Journal of Cell Biology, 115 (2), pp. 447-459Winter, C.G., Saotome, Y., Levison, S.W., Hirsh, D., A role for ciliary neurotrophic factor as an inducer of reactive gliosis, the glial response to central nervous system injury (1995) Proc. Natl. Acad. Sci. U.S.A., 92, pp. 5865-5869Rezende, A.C., Vieira, A.S., Rogério, F., Rezende, L.F., Boschero, A.C., Negro, A., Langone, F., Effects of systemic administration of ciliary neurotrophic factor on Bax and Bcl-2 proteins in the lumbar spinal cord of neonatal rats after sciatic nerve transection (2008) Braz J. Med. Biol. Res., 41, pp. 1024-1028Rezende, L.F., Stoppiglia, L.F., Souza, K.L.A., Negro, A., Langone, F., Boschero, A.C., Ciliary neurotrophic factor promotes survival of neonatal rat islets via the BCL-2 anti-apoptotic pathway (2007) Journal of Endocrinology, 195 (1), pp. 157-165. , DOI 10.1677/JOE-07-0016Wadt, K.A.W., Larsen, C.M., Andersen, H.U., Nielsen, K., Karlsen, A.E., Mandrup-Poulsen, T., Ciliary neurotrophic factor potentiates the β-cell inhibitory effect of IL-1β in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase (1998) Diabetes, 47 (10), pp. 1602-1608. , DOI 10.2337/diabetes.47.10.1602Jiang, J., Yamato, E., Miyazaki, J.-I., Long-term control of food intake and body weight by hydrodynamics-based delivery of plasmid DNA encoding leptin or CNTF (2003) Journal of Gene Medicine, 5 (11), pp. 977-983. , DOI 10.1002/jgm.433Sleeman, M.W., Garcia, K., Liu, R., Murray, J.D., Malinova, L., Moncrieffe, M., Yancopoulos, G.D., Wiegand, S.J., Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice (2003) Proceedings of the National Academy of Sciences of the United States of America, 100 (SUPPL. 2), pp. 14297-14302. , DOI 10.1073/pnas.2335926100Bluher, S., Moschos, S., Bullen Jr., J., Kokkotou, E., Maratos-Flier, E., Wiegand, S.J., Sleemann, M.W., Mantzoros, C.S., Ciliary neurotrophic factorAx15 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice (2004) Diabetes, 53 (11), pp. 2787-2796. , DOI 10.2337/diabetes.53.11.2787Ahima, R., Overcoming insulin resistance with CNTF (2006) Nat. Med., 12, pp. 511-512Watt, M.J., Dzamko, N., Thomas, W.G., Rose-John, S., Ernst, M., Carling, D., Kemp, B.E., Steinberg, G.R., CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK (2006) Nat. Med., 12, pp. 541-548Liu, Q.-S., Gao, M., Zhu, S.-Y., Li, S.-J., Zhang, L., Wang, Q.-J., Du, G.-H., The novel mechanism of recombinant human ciliary neurotrophic factor on the anti-diabetes activity (2007) Basic and Clinical Pharmacology and Toxicology, 101 (2), pp. 78-84. , DOI 10.1111/j.1742-7843.2007.00092.xMatthews, V.B., Febbraio, M.A., CNTF: A target therapeutic for obesity-related metabolic disease? (2008) J. Mol. Med., 86, pp. 353-361Steinberg, G.R., Watt, M.J., Ernst, M., Birnbaum, M.J., Kemp, B.E., Jørgensen, S.B., Ciliary neurotrophic factor stimulates muscle glucose uptake by a PI3-kinase-dependent pathway that is impaired with obesity (2009) Diabetes, 58, pp. 829-839Rezende, L.F., Vieira, A.S., Negro, A., Langone, F., Boschero, A.C., Ciliary neurotrophic factor (CNTF) signals through STAT3- SOCS3 pathway and protects rat pancreatic islets from cytokine-induced apoptosis (2009) Cytokine, 46, pp. 65-71Sleeman, M.W., Anderson, K.D., Lambert, P.D., Yancopoulos, G.D., Wiegand, S.J., The ciliary neurotrophic factor and its receptor, CNTFRα (2000) Pharmaceutica Acta Helvetiae, 74 (2-3), pp. 265-272. , DOI 10.1016/S0031-6865(99)00050-3, PII S0031686599000503Rajan, P., Symes, A.J., Fink, J.S., STAT proteins are activated by ciliary neurotrophic factor in cells of central nervous system origin (1996) Journal of Neuroscience Research, 43 (4), pp. 403-411. , DOI 10.1002/(SICI)1097-4547(19960215)43:4<403::AID-JNR2>3.0.CO;2-JKisseleva, T., Bhattacharya, S., Braunstein, J., Schindler, C.W., Signaling through the JAK/STAT pathway, recent advances and future challenges (2002) Gene, 285 (1-2), pp. 1-24. , DOI 10.1016/S0378-1119(02)00398-0, PII S0378111902003980Levy, D.E., Darnell Jr., J.E., STATs: Transcriptional control and biological impact (2002) Nature Reviews Molecular Cell Biology, 3 (9), pp. 651-662. , DOI 10.1038/nrm909Wormald, S., Hilton, D.J., Inhibitors of Cytokine Signal Transduction (2004) Journal of Biological Chemistry, 279 (2), pp. 821-824. , DOI 10.1074/jbc.R300030200Karlsen, A.E., Ronn, S.G., Lindberg, K., Johannesen, J., Galsgaard, E.D., Pociot, F., Nielsen, J.H., Billestrup, N., Suppressor of cytokine signaling 3 (SOCS-3) protects β-cells against interleukin-1β- and interferon-γ-mediated toxicity (2001) Proceedings of the National Academy of Sciences of the United States of America, 98 (21), pp. 12191-12196. , DOI 10.1073/pnas.211445998Karlsen, A.E., Heding, P.E., Frobose, H., Ronn, S.G., Kruhoffer, M., Orntoft, T.F., Darville, M., Billestrup, N., Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1β-mediated toxicity through inhibition of multiple nuclear factor-κB-regulated proapoptotic pathways (2004) Diabetologia, 47 (11), pp. 1998-2011. , DOI 10.1007/s00125-004-1568-3Mori, H., Shichita, T., Yu, Q., Yoshida, R., Hashimoto, M., Okamoto, F., Torisu, T., Yoshimura, A., Suppression of SOCS3 expression in the pancreatic β-cell leads to resistance to type 1 diabetes (2007) Biochemical and Biophysical Research Communications, 359 (4), pp. 952-958. , DOI 10.1016/j.bbrc.2007.05.198, PII S0006291X07012053Lindberg, K., Ronn, S.G., Tornehave, D., Richter, H., Hansen, J.A., Romer, J., Jackerott, M., Billestrup, N., Regulation of pancreatic β-cell mass and proliferation by SOCS-3 (2005) Journal of Molecular Endocrinology, 35 (2), pp. 231-243. , DOI 10.1677/jme.1.01840Laubner, K., Kieffer, T.J., Lam, N.T., Niu, X., Jakob, F., Seufert, J., Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic β-cells (2005) Diabetes, 54 (12), pp. 3410-3417. , http://diabetes.diabetesjournals.org/cgi/reprint/54/12/3410, DOI 10.2337/diabetes.54.12.3410Nakata, M., Okada, T., Ozawa, K., Yada, T., Resistin induces insulin resistance in pancreatic islets to impair glucose-induced insulin release (2007) Biochemical and Biophysical Research Communications, 353 (4), pp. 1046-1051. , DOI 10.1016/j.bbrc.2006.12.134, PII S0006291X06028178Chandra, J., Zhivotovsky, B., Zaitsev, S., Juntti-Berggren, L., Berggren, P.-O., Orrenius, S., Role of apoptosis in pancreatic β-cell death in diabetes (2001) Diabetes, 50 (SUPPL. 1), pp. S44-S47Mandrup-Poulsen, T., β Cell death and protection (2003) Ann. N.Y. Acad. Sci., 1005, pp. 32-42Santos, G.J., Oliveira, C.A., Boschero, A.C., Rezende, L.F., CNTF protects MIN6 cells against apoptosis induced by Alloxan and IL-1β through down-regulation of the AMPK pathway (2011) Cell Signal., 23, pp. 1669-1676Rønn, S.G., Börjesson, A., Bruun, C., Heding, P.E., Frobøse, H., Mandrup-Poulsen, T., Karlsen, A.E., Billestrup, N., Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection (2008) Diabetologia, 51, pp. 1873-1882Börjesson, A., Rønn, S.G., Karlsen, A.E., Billestrup, N., Sandler, S., β-Cell specific overexpression of suppressor of cytokine signalling- 3 does not protect against multiple low dose streptozotocin induced type 1 diabetes in mice (2011) Immunol. Lett, 136, pp. 74-79Stephanou, A., Latchman, D.S., Opposing actions of STAT-1 and STAT-3 (2005) Growth Factors, 23 (3), pp. 177-182. , DOI 10.1080/08977190500178745, PII P65831023273422Hong, F., Jaruga, B., Kim, W.H., Radaeva, S., El-Assal, O.N., Tian, Z., Nguyen, V.-A., Gao, B., Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: Regulation by SOCS (2002) Journal of Clinical Investigation, 110 (10), pp. 1503-1513. , DOI 10.1172/JCI200215841Norkina, O., Dolganiuc, A., Catalano, D., Kodys, K., Mandrekar, P., Syed, A., Efros, M., Szabo, G., Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes (2008) Alcohol Clin. Exp. Res., 32, pp. 1565-1573Qing, Y., Stark, G.R., Alternative activation of STAT1 and STAT3 in response to interferon-β (2004) Journal of Biological Chemistry, 279 (40), pp. 41679-41685. , DOI 10.1074/jbc.M406413200Fasler-Kan, E., Suenderhauf, C., Barteneva, N., Poller, B., Gygax, D., Huwyler, J., Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3 (2010) Brain Res., 1354, pp. 15-22Meraz, M.A., White, J.M., Sheehan, K.C.F., Bach, E.A., Rodig, S.J., Dighe, A.S., Kaplan, D.H., Schreiber, R.D., Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway (1996) Cell, 84 (3), pp. 431-442. , DOI 10.1016/S0092-8674(00)81288-XMoore, F., Naamane, N., Colli, M.L., Bouckenooghe, T., Ortis, F., Gurzov, E.N., Igoillo-Esteve, M., Eizirik, D.L., STAT1 is a master regulator of pancreatic β-cell apoptosis and islet inflammation (2011) J. Biol. Chem., 286, pp. 929-941Kim, J.Y., Song, E.H., Lee, S., Lim, J.H., Choi, J.S., Koh, I.U., Song, J., Kim, W.H., The induction of STAT1 gene by activating transcription factor 3 contributes to pancreatic β-cell apoptosis and its dysfunction in streptozotocin-treated mice (2010) Cell Signal, 22, pp. 1669-1680Flodstrom, M., Tyrberg, B., Eizirik, D.L., Sandler, S., Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes (1999) Diabetes, 48 (4), pp. 706-713Yasuda, H., Jin, Z., Nakayama, M., Yamada, K., Kishi, M., Okumachi, Y., Arai, T., Nagata, M., NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes (2009) Diabetes Res. Clin. Pract., 83, pp. 200-207Van Belle, T.L., Coppieters, K.T., Von Herrath, M.G., Type 1 diabetes: Etiology, immunology, and therapeutic strategies (2011) Physiol. Rev., 91, pp. 79-118Rink, J.S., Chen, X., Zhang, X., Kaufman, D.B., Conditional and specific inhibition of NF-κB in mouse pancreatic β cells prevents cytokine- Induced deleterious effects and improves islet survival posttransplant (2011) Surgery, 151, pp. 330-339Del, P.S., Wishner, W.J., Gromada, J., Schluchter, B.J., β-Cell mass plasticity in type 2 diabetes (2004) Diabetes, Obesity and Metabolism, 6 (5), pp. 319-331. , DOI 10.1111/j.1462-8902.2004.00360.xRhodes, C.J., Type 2 diabetes-a matter of β-cell life and death? (2005) Science, 307, pp. 380-384Rezende, L.F., Santos, G.J., Santos-Silva, J.C., Carneiro, E.M., Boschero, A.C., Ciliary neurotrophic factor (CNTF) protects nonobese Swiss mice against type 2 diabetes by increasing beta cell mass and reducing insulin clearance (2012) Diabetologia, 55, pp. 1495-1504Ettinger, M.P., Littlejohn, T.W., Schwartz, S.L., Weiss, S.R., McIlwain, H.H., Heymsfield, S.B., Bray, G.A., Guler, H.-P., Recombinant Variant of Ciliary Neurotrophic Factor for Weight Loss in Obese Adults: A Randomized, Dose-Ranging Study (2003) Journal of the American Medical Association, 289 (14), pp. 1826-1832. , DOI 10.1001/jama.289.14.182